SGMO Stock Summary and Trading Ideas (Sangamo Therapeutics | :SGMO)

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its neurology development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases and development of novel engineered adeno-associated virus, or AAV, capsids to deliver its therapies to the intended neurological targets. The group's pipeline products are Small Fiber Neuropathy, Prion Disease, Tauopathies, ALS/FTD, Huntington's Disease, Fabry Disease, and Hemophilia A.

What symbol and exchange does Sangamo Therapeutics shares trade?

Sangamo Therapeutics trades on the stock market under the symbol SGMO.

What is Sangamo Therapeutics stock price doing today?

As of May 29, 2026, SGMO stock price was flat at $0.18 with million shares trading.

What is Sangamo Therapeutics's Beta?

SGMO has a beta of 1.65, meaning it tends to be more sensitive to market movements. SGMO has a correlation of 0.04 to the broad based SPY ETF.

How much is Sangamo Therapeutics worth?

SGMO has a market cap of $73.58 million. This is considered a Micro Cap stock.

How much money does Sangamo Therapeutics make?

Last quarter Sangamo Therapeutics reported $1 million in Revenue and -$.08 earnings per share. This fell short of revenue expectation by $-27 million and missed earnings estimates by -$.02.

What is the highest and lowest price Sangamo Therapeutics traded in the last 3 year period?

In the last 3 years, SGMO traded as high as $3.18 and as low as $.12.

What are the top ETFs holding Sangamo Therapeutics?

The top ETF exchange traded funds that SGMO belongs to (by Net Assets): VTI, VXF.

Is Sangamo Therapeutics (SGMO) a good investment?

SGMO has underperformed the market in the last year with a price return of -60.7% while the SPY ETF gained +30.0%. SGMO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -58.9% and 0.0%, respectively, while the SPY returned +10.5% and +1.1%, respectively.

What are the support and resistance levels for Sangamo Therapeutics (SGMO)?

SGMO support price is $.17 and resistance is $.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGMO shares will trade within this expected range on the day.